NEW TECHNOLOGY FOR 1 MICRON RESOLUTION BIOMEDICAL IMAGING
The 1MICRON project aims to revolutionize cancer detection by developing high-resolution, integrated x-ray sensors for immediate surgical feedback, potentially saving over 100,000 treatments annually in Europe.
Projectdetails
Introduction
The 1MICRON project can bridge the gap in image quality between today’s digital x-ray detectors and histopathology. We will integrate CMOS electronics circuits directly into the sensor, employing an edge-on "deep silicon" geometry for monolithic sensors that ensure high efficiency.
Technological Breakthrough
This breakthrough promises a remarkable order of magnitude improvement in spatial resolution, all the way down to 1 micron. Such a high-resolution sensor will make phase contrast imaging much more practical and efficient, and as a secondary effect, this will dramatically increase the contrast in the images.
Impact on Pathology Analysis
Today’s pathology analysis takes weeks, and when cancer cells are found at the margin or in sentinel nodes, the patient is called back for corrective surgery, which delays treatment and decreases survival chances.
Application in Surgical Settings
The 1MICRON imaging technology can be used directly in the operating room, providing a digitized 3D volume for immediate feedback on cancer margins. The new method can save over 100,000 surgical treatments per year only in Europe, saving the corresponding costs for the healthcare system.
Market Expansion
The technology could also be implemented in new markets such as developing countries, where today pathology laboratories are not accessible.
Secondary Objectives
A secondary objective is to provide a proof-of-principle for a new sensor for next-generation CT, coping with high x-ray flux and having low enough power consumption for future implementation in a clinical modality. The high resolution can provide a “3D virtual biopsy” as an alternative to today’s invasive needle biopsies.
Team Expertise
Our team includes leading European experts in medical imaging, phase-contrast imaging, monolithic sensor design, pathology, radiology, surgery, and industry, positioning us uniquely to undertake this ambitious project.
Conclusion
Our success can trigger a paradigm shift in both pathology and clinical x-ray imaging, corresponding to the most significant advancement in decades.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.999.999 |
Totale projectbegroting | € 2.999.999 |
Tijdlijn
Startdatum | 1-3-2025 |
Einddatum | 28-2-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- KUNGLIGA TEKNISKA HOEGSKOLANpenvoerder
- KAROLINSKA INSTITUTET
- TECHNISCHE UNIVERSITAET MUENCHEN
- UNIVERSITA DEGLI STUDI DI TRENTO
- ISTITUTO NAZIONALE DI FISICA NUCLEARE
- PRISMATIC SENSORS AB
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTIONRETIMAGER aims to revolutionize PET imaging by achieving ten-fold improvements in spatial and temporal resolution, enabling real-time, high-sensitivity imaging for personalized precision medicine. | EIC Pathfinder | € 3.126.347 | 2023 | Details |
Next generation Limited-Angle time-of-flight PET imagerThe PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings. | EIC Pathfinder | € 3.374.041 | 2023 | Details |
MHz rate mulTiple prOjection X-ray MicrOSCOPYThis project aims to revolutionize 4D X-ray microscopy by enabling MHz-rate imaging of fast processes in opaque materials, unlocking new insights for various industries. | EIC Pathfinder | € 3.154.350 | 2022 | Details |
integrated nano-photonic OMICs bio-SENSor for lung cancerOMICSENS aims to develop a novel nano-photonic omics bio-sensor for real-time detection of TKI resistance in NSCLC, enhancing prognosis and paving the way for personalized cancer treatment. | EIC Pathfinder | € 2.372.318 | 2024 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.
REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTION
RETIMAGER aims to revolutionize PET imaging by achieving ten-fold improvements in spatial and temporal resolution, enabling real-time, high-sensitivity imaging for personalized precision medicine.
Next generation Limited-Angle time-of-flight PET imager
The PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings.
MHz rate mulTiple prOjection X-ray MicrOSCOPY
This project aims to revolutionize 4D X-ray microscopy by enabling MHz-rate imaging of fast processes in opaque materials, unlocking new insights for various industries.
integrated nano-photonic OMICs bio-SENSor for lung cancer
OMICSENS aims to develop a novel nano-photonic omics bio-sensor for real-time detection of TKI resistance in NSCLC, enhancing prognosis and paving the way for personalized cancer treatment.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields. | ERC Advanced... | € 3.351.875 | 2024 | Details |
Advanced X-ray Energy-sensitive Microscopy for Virtual HistologyThis project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions. | ERC Consolid... | € 2.000.000 | 2023 | Details |
MUlti-spectral Scattering matrix for Enhanced skin imagingThe ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization. | ERC Proof of... | € 150.000 | 2024 | Details |
Enabling the transition to 3D digital pathology3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally. | EIC Transition | € 2.493.683 | 2025 | Details |
In vivo Immunofluorescence-Optical Coherence TomographyDevelop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease. | ERC Advanced... | € 2.500.000 | 2025 | Details |
3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.
This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields.
Advanced X-ray Energy-sensitive Microscopy for Virtual Histology
This project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions.
MUlti-spectral Scattering matrix for Enhanced skin imaging
The ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization.
Enabling the transition to 3D digital pathology
3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.
In vivo Immunofluorescence-Optical Coherence Tomography
Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.